Hey Pnnymn...
I think investors are becoming impatient or nervous and taking their money to other opportunities in the meantime to make a few bucks while waiting for "October" to swing around. Also, the charts are pointing to a dip towards support, so traders are playing that game as well.
I see that as a short-sighted. I'm long. I'll wait it out. Here's why...
How often do you get a company with a breakthrough solution to a worldwide problem, who has the right connections and experience to deliver that solution, and you are able to get in at a $1B market cap?
If an FDA announcement comes, it is likely to come outside market hours, or they will halt trading to make the announcement. Either way, I'm pretty sure the stock will be long-gone from these levels before the typical retail investor is able to get in.
I'm not willing to risk missing the FDA announcement or any other significant news, as it could come at any moment between now and the next 45 days.
If I KNEW FOR CERTAIN the stock was going to be in the dollars-range within the next 45 days, I wouldn't be concerned at all about interim price swings. Now... I'm not certain, but I do have confidence in the leadership team's experience and connections, what we know about the drug's prior performance (and future potential), and the FDA progress so far.
(This is all my opinion only and NOT trading or investing advice. I could be dead wrong.)
News 
Market Data 
Discover 
